LON:BXP Beximco Pharmaceuticals (BXP) Share Price, News & Analysis → The last Republican president? (From The Freeport Society) (Ad) Free BXP Stock Alerts GBX 37.66 -0.84 (-2.18%) (As of 07:37 AM ET) Add Compare Share Share Today's Range 37.66▼ 38.5050-Day Range 36.08▼ 4152-Week Range 33.56▼ 45Volume17,750 shsAverage Volume60,714 shsMarket Capitalization£168.01 millionP/E Ratio470.75Dividend Yield7.97%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Beximco Pharmaceuticals alerts: Email Address Ad Porter & CompanyThe Key to this $10 Trillion Tech BoomPresident Biden has just approved $2.6 billion for this breakthrough technology… And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.To get all the details of this new tech – click here now. About Beximco Pharmaceuticals Stock (LON:BXP)Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.Read More BXP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BXP Stock News HeadlinesFebruary 15, 2024 | lse.co.ukBeximco Pharma Share ChatDecember 14, 2023 | morningstar.comBeximco Pharmaceuticals Ltd DRNovember 4, 2023 | investing.comBeximco Pharmaceuticals Ltd. (BXPq)June 9, 2023 | finance.yahoo.comBXP.L - Beximco Pharmaceuticals LimitedMarch 12, 2023 | msn.comBeximco to produce medicines in Saudi Arabia from next yearFebruary 11, 2023 | fool.co.ukBeximco PharmaceuticalsOctober 26, 2022 | wsj.comBeximco Pharmaceuticals Ltd.September 8, 2022 | investing.comBeximco Pharmaceuticals Ltd (BXPH)January 20, 2022 | nasdaq.comBeximco Pharma Granted Sub-license To Produce Molupiravir - Quick FactsNovember 9, 2021 | nasdaq.comBeximco Pharma Launches Generic Molnupiravir In Bangladesh To Treat Symptomatic COVID-19August 2, 2021 | barrons.comBeximco Pharmaceuticals Ltd. GDRSee More Headlines Receive BXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolLON:BXP CUSIPN/A CIKN/A Webwww.beximco-pharma.com Phone+880-2-58611001FaxN/AEmployees5,700Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.08 Trailing P/E Ratio470.75 Forward P/E Ratio4.21 P/E GrowthN/ANet Income£5.33 billion Net Margins12.37% Pretax MarginN/A Return on Equity10.99% Return on Assets6.97% Debt Debt-to-Equity Ratio14.73 Current Ratio1.80 Quick Ratio0.37 Sales & Book Value Annual Sales£43.08 billion Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares446,110,000Free FloatN/AMarket Cap£168.01 million OptionableNot Optionable Beta0.63 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Mohammad Ali NawazChief Financial OfficerMr. S. M. Rabbur RezaChief Operating OfficerMr. Jamal Ahmed ChoudhuryDirector of Accounts & FinanceMr. Rizvi Ul KabirDirector of MarketingMr. M. A. Arshad BhuiyanGeneral Manager of Human ResourcesMr. Zakaria Seraj ChowdhuryHead of Distribution Services & Director of International MarketingMr. Mohammad Asad Ullah FCSCompany Secretary & Executive DirectorMore ExecutivesKey CompetitorsAmryt PharmaLON:AMYTBenchmarkLON:BMKAllergy TherapeuticsLON:AGYAlliance PharmaLON:APHAnimalcare GroupLON:ANCRView All Competitors BXP Stock Analysis - Frequently Asked Questions How have BXP shares performed in 2024? Beximco Pharmaceuticals' stock was trading at GBX 41.50 on January 1st, 2024. Since then, BXP stock has decreased by 9.3% and is now trading at GBX 37.66. View the best growth stocks for 2024 here. Is Beximco Pharmaceuticals a good dividend stock? Beximco Pharmaceuticals (LON:BXP) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 6.21%. BXP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 3,750.00%. Payout ratios above 75% are not desirable because they may not be sustainable. How do I buy shares of Beximco Pharmaceuticals? Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:BXP) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.